Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangqi Jing Granules (黄芪精颗粒) is a traditional Chinese medicine (TCM) manufactured by Chengde JingFuKang Pharmaceutical Group. It is an oral granule formulation derived from the extract of *Astragalus membranaceus* (Huangqi). In the framework of TCM, it is classified as a tonic (补益类) used to replenish Qi, nourish blood, and consolidate the 'exterior' (the body's first line of defense). It is primarily indicated for the treatment of Qi and blood deficiency, which presents as fatigue, shortness of breath, spontaneous sweating, and general physical weakness. The product is approved and marketed in China as an over-the-counter (OTC) medication for general supportive and strengthening purposes, often used to aid recovery from illness or to manage chronic fatigue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huangqi Jing Granules.